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Purpose: The purpose of this project was to develop an
educational program to nurses as they assume cardiac
monitoring responsibilities on an adult inpatient Blood and
Marrow Transplant unit.
Background: Blood and Marrow patients are at risk for
cardiac toxicities related to the high-dose chemotherapy
they receive as part of their conditioning regimen. By initi-
ating cardiac monitoring on the BMT unit continuity of care
could be maintained by educating Blood and Marrow
Transplant nurses to use the cardiac monitor, manage select
arrhythmias and administer speciﬁc medications to treat the
cardiac situation.
Method:With no cardiac patients or equipment, our biggest
challenge was how to educate nurses to take cardiac
patients on day one after our move. We began our multi-
modal approach with a three day class provided by the
critical care orientation team. We prepared a bucket of
practice strips, led one to one and group learning sessions,
and read 12 lead EKGs to keep our knowledge fresh. All
nurses were required to complete a cardiac arrhythmia test
with an 80% pass threshold. They also attended a mandatory
four hour class run by BMT leadership nurses that included
review of rhythms, Cardiac Monitoring Jeopardy, hands-on
practice with the monitor, scenarios in our hospital's
simulation laboratory. Once telemetry began, staff members
from the hospital's rapid response team rounded daily to
review strip interpretation and consult with nurses as
needed.
Results: A total of 60 nurses completed the program before
initiation of cardiac monitoring. All nurses independently
care for patients onmonitors and usemonitors for vital signs.
Zero patients have transferred to the telemetry unit and RRT
continues support for rhythm checks. We continue to
present the cardiac orientation program to new BMT nurses
along with precepted time with monitored patients to help
them feel prepared for independent practice.512
Providing Cultural Competent Care
Marcella J. Harris. ABMT Unit, Duke University Hospital
Our Adult Blood and Marrow Transplant Program at
a tertiary health care center is a leader in clinical care and
bio-medical research. Patient centered care is the funda-
mental framework of our organization. Many patients from
diverse cultural backgrounds from across our nation and
the world travel here, seeking our care. With this growth
in diversity, it is critical that as health care providers we
understand their particular needs. It is also in our best
interest to provide care that is culturally competent. The
“Advancing effective communication, cultural competence,
and patient and family centered care: A Roadmap for
Hospitals” article, published in August 2010, provides
recommendations to help hospitals address unique patient
needs and comply with existing joint commission
requirements. Firstly, our organization purchased a Culture
Vision database to help health care providers learn about
speciﬁc cultures. Then, our ABMT unit took steps to
embrace culturally competent care by integrating
a cultural knowledge. The nursing staff completed an
assessment of their own healthcare beliefs and practices,
and existing cultural knowledge. Then, we enlisted the
help of nursing staff from different cultural backgroundsto share their experience in the context of their
culture's perception of illness, pain, healing, attitudes
toward authority ﬁgures, use of nonverbal and verbal
communication and its interpretations, spiritual and death
practices, and the role of family within the speciﬁc group.
Unit based nursing grand rounds during staff meetings
included presentations from staff members of Latino,
African, Caribbean, Native American, and Arabic back-
ground. Our focus of presenting unbiased information
about the potential cultural behavior of patient's, resulted
in tearing down barriers and providing optimal patient
care. More importantly, this project helped members of the
nursing staff become more aware of our own traditions
and motivated us to recognize, respect, and take into
account beliefs and practices of our patients. It is no
surprise, that health care providers who understand their
patients’ cultural values, beliefs and practices are more
likely to have positive interactions with their patients and
provide them with culturally acceptable care. When we
embrace other cultures, we learn to understand, accept
and respect differences while fostering trusting relation-
ships with our patients and their family members.513
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Background: Allogeneic hematopoietic stem cell trans-
plantation (HSCT) is a life-saving measure for malignant
hematologic disorders. Infection during neutropenia,
however, is amajor cause of transplant relatedmorbidity and
mortality (TRM). The use of granulocyte colony stimulating
factor (GCSF) following HSCT has become a standard of care
in many institutions. Although several retrospective studies
reported that it accelerates neutrophil recovery by 1-6 days,
other meta analyses have failed to demonstrate any signiﬁ-
cant difference in the days of febrile neutropenia. The
CIBMTR working group that reviewed outcomes of patients
who received GCSF during HSCT found no beneﬁt or risk in
those with myeloid leukemia but no improvement in early
TRM despite faster neutrophil recovery. Notably, there have
been no standards published regarding its use or timing of
use in this setting.
Methods: First a review of the published literature on the
use of GCSF in the HSCT setting was performed to
summarize study ﬁndings and recommendations. Second,
a survey was undertaken of the use GCSF at 15 transplant
centers. Questions included: timing of initiation, duration of
therapy, and association with stem cell source and intensity
of conditioning. Finally, a cost analysis was performed using
standard charges to estimate the cost of various GCSF
regimens.
Results: Thus far 8 of the 15 centers have responded. The
volume of transplants/center ranged from 126-519/year. Use
of GCSF is summarized in Table 1.
Cost analysis: The standard charge for GCSF is approx.
$1.00/mcg and ranged from $300-800/dose. Thus cost for
GCSF regimens beginning on D0 vs. D+7 for treatment to
D+14 could be $4200-11200 vs $2100-5600. These are
compared to centers that do not utilize GCSF at all where
the cost is $0.
Conclusions: Despite the lack of supportive data for the use
of GCSF following HSCT, several trials/analyses that
Table 1
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reports of detrimental effect, the majority of responding
transplant centers continue its use. Furthermore, timing for
initiating GCSF varied from D0 to D+12 in those centers.Table 1
Institution # Cords RIC/nonmyeloablative
BM/PBSC
Myeloablative
BM/PBSC
1 D+1 Not used Not used
2 D+1 D+7 D+7
3 D+7 D+7 D+7
4 D+1 Not used Not used
5 D+1 Prn MD/clinical status Prn MD/clinical status
6 D+5 D+5 D+12
7 Not used Not used Not used
8 D0 D+5 D0
team member (n¼53) (n¼19) (n¼15) implemented
(n¼3)
proposed
(n¼3)
Blood Bank 1
Chaplain 1
Dietitian 0 1
PBMT
Attending
Physician
4 1 1 1*^# 1
PBMT
Hospitalist
4 1 2
PBMT
Child-Life
Specialist
1 0 1
PBMT Nurse 31 7 5 1^
PBMT Nurse
Practitioner
4 4 1 1* 1+
PBMT
Pharmacist
1 1 1#
PBMT Social
Worker
2 2 1
Pediatric
Hematology-
Oncology
Fellow
3 1 1
Palliative Care 2 1 1+
Psychologist 1 0 1
+^*# indicates collaborationIn the current environment of reducing healthcare
costs, these ﬁndings suggest the need for reevaluation of
its use.
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A Multidisciplinary Intervention Fosters Dissemination
and Rapid Implementation of Evidence Based Medicine
Dawn Landery 1, Kathryn Elison 1, Jonelle Gray 1,
Kris Michael Mahadeo 2. 1 Bone Marrow Transplant, Children's
Hospital Los Angeles, Los Angeles, CA; 2 Research Immunology
and Bone Marrow Transplant, Children's Hospital Los Angeles,
Los Angeles, CA
Research regarding the promotion of evidence based
medicine (EBM) suggests that a common barrier to the
transition from knowledge acquisition to implementation
may be a lack of acceptance from other members of the
multidisciplinary healthcare team. A needs assessment
conducted on our Pediatric Blood and Marrow Trans-
plantation (PBMT) unit suggested that a journal club
would be an effective method to promote EBM. A multi-
disciplinary journal club (MJC) was introduced to: (i)
promote new, valid and relevant evidence into the clinical
pipeline; (ii) reduce barriers to implementation of new
innovations associated with lack of multidisciplinary
collaboration; (iii) foster multidisciplinary communication;
(iv) generate new ideas for research; (v) promote
EBM. Each month, 3 presenters discussed articles related
to their individual scope of practice, related to PBMT.
Articles were screened for relevance, innovation and
validity by members of a MJC committee. Attendees/
presenters included PBMT team members and members
of healthcare teams which frequently interact with PBMT.
A group discussion followed each presentation with
regard to relevance, applicability and implementation of
innovations presented. A survey was conducted after 7
consecutive MJCs to determine its impact. Characteristics
of attendees (n¼53) and presenters (n¼19) are shown in
Table 1. 100% of PBMT physicians, hospitalists, social
workers, nurse practitioners and child life specialists and
50% PBMT nurses attended more than one MJC. Results of
the impact survey demonstrated that 90% of respondents
(n¼21) “thought the articles presented were relevant to
their clinical practice.” 67% reported that they gained new
insights by attending MJC and could identify speciﬁc ways
to apply concepts discussed. At least six innovations were
implemented (changes in practice [n¼3] and multidisci-
plinary research proposals [n¼3]) over seven months, asa direct result of articles presented at MJC (Table 1). Most
successfully implemented innovations involved collabora-
tion between multidisciplinary team members.
Promotion of EBM can be achieved by a multidisciplinary
approach. A MJC allows for rapid implementation of
innovation by promoting more simultaneous acceptance
from all members of the multidisciplinary healthcare
team.515
Moving Practice Forward: Standardization of Infusion
Times for Hematopoietic Cells Utilizing an IV Pump
Theresa Latchford. Nursing, Stanford Hospital and Clinics, Los
Gatos, CA
Signiﬁcance: BMT recipients have a 12F central venous
catheter (CVC) placed prior to transplant to accommodate
hydration, medications, and blood testing. This catheter is
also required to ensure rapid infusion of hematopoietic cell
products via gravity. Variation of cell product infusion times
exists during gravity infusions related to patient symptoms,
patency of the CVC, rate at which the nurse infuses the
product, types of cells infused. Standardizing the cell
product infusion time utilizing an IV pump eliminates
variation and provides both the nurse and patient with
a better experience.
Purpose: The main purpose was to determine if hemato-
poietic cells infused via IV infusion pump over a set period of
time provided patients with less symptoms than gravity
infusions and nurses with a more efﬁcient way of delivering
cells.
Interventions: Practices of hematopoietic cell infusions at
other transplant centers were assessed. Cell viability of cry-
opreserved cell products after utilizing an IV pump for
infusion was determined. Samples of frozen products were
infused via IV infusion pump to determine cell viability post
infusion. A new procedure was written to infuse
